Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis

被引:157
|
作者
Lemoine, M. [1 ]
Katsahian, S. [2 ]
Ziol, M. [3 ]
Nahon, P. [1 ]
Ganne-Carrie, N. [1 ]
Kazemi, F. [1 ]
Grando-Lemaire, V. [1 ]
Trinchet, J. -C. [1 ]
Beaugrand, M. [1 ]
机构
[1] Hop Jean Verdier, AP HP, Serv Hepatol, F-93143 Bondy, France
[2] Hop St Louis, AP HP, Dept Biostat & Informat Med, Paris, France
[3] Hop Jean Verdier, Dept Anatomopathol, F-93143 Bondy, France
关键词
D O I
10.1111/j.1365-2036.2008.03825.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Hepatic venous pressure gradient (HVPG) is the gold standard for assessing the presence and the severity of portal hypertension (PHT). Liver stiffness measurement (LSM) is a non-invasive method for liver fibrosis assessment. Aims To assess the relationship between LSM and HVPG in patients with compensated cirrhosis related to hepatitis C virus (HCV) or alcohol and to define the performance and the best cut-off of LSM for the diagnosis of PHT in these patients. Methods Between January 2004 and September 2006, we studied all the consecutive patients with compensated HCV or alcohol-related-cirrhosis referred for transjugular liver biopsy with HVPG measurement and LSM performed the same day. Results Ninety-two patients were eligible, 44 had HCV related-cirrhosis and 48 alcoholic cirrhosis. LSM was positively correlated to HVPG in both groups. The area under the receiver operating characteristic curve for the diagnosis of significant PHT was 0.76 +/- 0.07 in HCV patients (best cut-off at 20.5 kPa) and 0.94 +/- 0.03 (best cut-off at 34.9 kPa) in alcoholic patients. Conclusions Liver stiffness measurement and HVPG were significantly correlated in patients with compensated cirrhosis because of HCV infection or alcohol. LSM could predict significant PHT in both these groups of patients with a higher cut-off and a better performance in alcoholic patients.
引用
收藏
页码:1102 / 1110
页数:9
相关论文
共 50 条
  • [1] Predicting clinically significant portal hypertension in chronic hepatitis C related cirrhosis
    Gordon, A
    Mitchell, J
    Morales, BM
    Bailey, MJ
    Angus, PW
    Roberts, SK
    GASTROENTEROLOGY, 2004, 126 (04) : A731 - A731
  • [2] PLATELET ENHANCES THE ACCURACY OF SPLEEN STIFFNESS MEASUREMENT AND LIVER STIFFNESS MEASUREMENT TO PREDICT CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN CIRRHOSIS PATIENTS
    Wong, Yu Jun
    Lim, Geraldine
    Yap, Siew Yoon
    Zhang, Yajie
    Toh, Juyuan
    Yap, Carolyn
    Tan, Jessica
    Kumar, Rahul
    HEPATOLOGY, 2023, 78 : S1405 - S1406
  • [3] Noninvasive prediction of clinically significant portal hypertension and esophageal varices in patients with compensated liver cirrhosis
    Berzigotti, Annalisa
    Gilabert, Rosa
    Abraldes, Juan G.
    Nicolau, Carlos
    Bru, Concepcion
    Bosch, Jaime
    Garcia-Pagan, Juan C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (05): : 1159 - 1167
  • [4] Persistence of Clinically Significant Portal Hypertension After Eradication of Hepatitis C Virus in Patients With Advanced Cirrhosis
    Diez, Cristina
    Berenguer, Juan
    Ibanez-Samaniego, Luis
    Llop, Elba
    Perez-Latorre, Leire
    Catalina, Maria, V
    Hontanon, Victor
    Jimenez-Sousa, Maria A.
    Aldamiz-Echevarria, Teresa
    Martinez, Javier
    Luis Calleja, Jose
    Albillos, Agustin
    Bellon, Jose M.
    Resino, Salvador
    Gonzalez-Garcia, Juan
    Banares, Rafael
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : 2726 - 2729
  • [5] METABOLOMICS IMPROVES THE PREDICTION OF RISK OF DECOMPENSATION OR LIVER RELATED DEATH IN PATIENTS WITH COMPENSATED CIRRHOSIS AND CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
    Maria Nicoara-Farcau, Oana
    Jose Lozano, Juan
    Sidorova, Julia
    Villanueva Sanchez, Candido
    Albillos, Agustin
    Genesca, Joan
    Luis Calleja, Jose
    Aracil, Carles
    Banares, Rafael
    Maria Morillas, Rosa
    Poca Sans, Maria
    Penas, Beatriz
    Augustin, Salvador
    Perez-Campuzano, Valeria
    Hernandez-Gea, Virginia
    Abraldes, Juan G.
    Alvarado Tapias, Edilmar
    Torres, Ferran
    Bosch, Jaime
    Carlos Garcia-Pagan, Juan
    HEPATOLOGY, 2022, 76 : S155 - S156
  • [6] DIAGNOSIS OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH CIRRHOSIS: SPLENIC ARTERIAL RESISTIVE INDEX VERSUS LIVER STIFFNESS MEASUREMENT
    Lee, Chul-Min
    Jeong, Woo Kyoung
    Lim, Sanghyeok
    Kim, Yongsoo
    Kim, Jinoo
    Kim, Tae Yeob
    Sohn, Joo Hyun
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2016, 42 (06): : 1312 - 1320
  • [7] SPLEEN STIFFNESS MEASUREMENTS (SSM) IN THE IDENTIFICATION OF CLINICALLY-SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN PATIENTS WITH COMPENSATED CIRRHOSIS
    Ortiz, Guillermo A.
    Palumbo, Chiara
    Sayyar, Mubarak W.
    Balakrishnan, Maya
    Mohanty, Arpan
    Garcia-Tsao, Guadalupe
    GASTROENTEROLOGY, 2020, 158 (06) : S1385 - S1385
  • [8] Patients With Clinically Significant Portal Hypertension Caused by Hepatitis C Virus Cirrhosis Respond Poorly to Antiviral Therapy
    Grace, Norman D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2011, 9 (07) : 536 - 538
  • [9] Limited diagnostic value of liver stiffness for clinically significant portal hypertension in HBV-related cirrhosis
    Mengmeng Zhang
    Xiaoxia Niu
    Di Zhao
    Ruping Qi
    Xuexin Qi
    Jinghui Dong
    Yuan Liu
    Xu Bai
    Qiang Yu
    Changchun Liu
    Jianming Cai
    Abdominal Radiology, 2022, 47 : 3712 - 3723
  • [10] Limited diagnostic value of liver stiffness for clinically significant portal hypertension in HBV-related cirrhosis
    Zhang, Mengmeng
    Niu, Xiaoxia
    Zhao, Di
    Qi, Ruping
    Qi, Xuexin
    Dong, Jinghui
    Liu, Yuan
    Bai, Xu
    Yu, Qiang
    Liu, Changchun
    Cai, Jianming
    ABDOMINAL RADIOLOGY, 2022, 47 (11) : 3712 - 3723